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Abstract
Background: This study was conducted to examine, in vitro , the effect of soluble egg antigen
(SEA) of S. haematobium on intracellular HCV RNA load in peripheral mononuclear cells (PBMC)
as well as on cell proliferation in patients with chronic HCV infection.
Methods: PBMC from 26 patients with chronic HCV infection were cultured for 72 hours in
presence and absence of 50 μg SEA/ml medium. Intracellular HCV RNA quantification of plus and
minus strands was assessed before and after stimulation. PBMC from five healthy subjects were
cultured for 7 days, flow cytometric analysis of DNA content was used to assess the mitogenic
effect of SEA on PBMC proliferation compared to phytoheamaglutinine (PHA).
Results: Quantification of the intracellular viral load showed increased copy number/cell of both
or either viral strands after induction with SEA in 18 of 26 patients (69.2%) thus indicating
stimulation of viral replication. Flow cytometric analysis showed that mean ± S.D. of percent values
of cell proliferation was induced from 3.2 ± 1.5% in un-stimulated cells to 16.7 ± 2.5 % and 16.84
± 1.7 % in cells stimulated with PHA and SEA respectively.
Conclusion: the present study supports earlier reports on SEA proliferative activity on PBMC and
provides a strong evidence that the higher morbidity observed in patients co-infected with
schistosomiasis and HCV is related, at least in part, to direct stimulation of viral replication by SEA.
Background
Hepatitis C Virus (HCV) is the major agent in non A non
B hepatitis with serious complications ranging from
chronic inflammatory disease to hepatic cirrhosis and end
stage liver failure or hepatocellular carcinoma (HCC). It is
estimated that 170 millions world wide are infected with
HCV. Egypt has unusually high prevalence of hepatitis C
resulting in high morbidity and mortality from liver dis-
ease. Approximately 20% of blood donors are seroposi-
tive for HCV antibodies [1-5]. Schistosomiasis is another
hepatotropic infection with a major burden on Egyptian
patient population particularly in rural societies[1,6,7].
Co-infections with Schistosoma mansoni were repeatedly
shown to augment pathogenesis induced by HBV and
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HCV hepatitis [2,8,9]. Subjects co-infected with HCV
accelerate advancement of liver disease to the chronicity
of HCV infection, cirrhosis and hepatocellular carcinoma
and high incidence of viral persistence [10]. However sim-
ilar studies on Schistosoma haematibium derived SEA has
been scarcely reported.
Several reports attempted to reveal the underlying mecha-
nisms of the severity of co-infection. The majority of these
have focused on the role of growth factor rich soluble egg
antigen (SEA), in contrary to adult worm soluble antigens,
on angiogenic processes and granuloma formation medi-
ated by peripheral blood mononuclear cell (PBMC) [11]
and endothelial cell proliferation [12] through distinct
intracellular signaling pathway[13]. Such mitogenic activ-
ity of SEA was shown to be cell specific, dose dependent
and involves up regulation of cell cycle engine promoting
genes [14].
Although HCV titer was shown to be higher in patients co
infected with HCV and Schistosomiasis than patients with
HCV infection alone, direct data on the effect of SEA on
intracellular HCV replication in PBMC derived from
patients with chronic hepatitis C are yet unavailable. Thus
the rational of this study is to examine, in vitro , the influ-
ence of SEA on intracellular HCV RNA load in PBMC from
patients with chronic HCV infection. Careful study of cell
proliferation response to SEA allows analysis of relative
induction in intracellular viral load versus stimulation of
cell proliferation.
Methods
Subjects
Twenty six patients were enrolled in this study. All
patients had detectable HCV antibodies by third genera-
tion ELISA (Dia Sorin, Torino, Italy). Serum concentra-
tions of HCV RNA varied from 29 × 103 to 3 × 106 . Twenty
four patients had genotype 4 of HCV genome, while the
remaining two had 1b. None of the patients received treat-
ment for HCV. All the patients had undetectable levels of
HBsAg, schistosoma and HIV antibodies. Five subjects
served as controls for normal PBMC stimulation studies.
None of the 5 control subjects had detectable sero mark-
ers for viral or parasitic infections.
Methods
Effect of SEA on cell proliferation
A lyophilized preparation of the soluble fraction of
mature live S. haematobium eggs was supplied by Theod-
ore Bilharz Research Institute, Imbaba, Egypt.
Ten ml blood were collected from each normal control
subject [approved by the medical ethical committee of the
National research center (NRC)] and PBMC were sepa-
rated from whole blood using Ficoll separating solution.
Cells were washed with PBS three times. Mixtures were
then centrifuged at 1600 rpm for 10 min to collect the
washed cell pellet. After the last wash, cells were re-sus-
pended in 1 ml RPMI-1640, supplemented with 10% FCS,
counted and adjusted with RPMI to be 0.75 million cells/
ml media. Cells were then plated into a 6 well plate at 2
million cells per well. A preliminary experiment was done
to explore the optimum concentration of SEA that induces
cell proliferation. Cells were treated with 10, 50, 100 and
150 μg/ml culture of SEA. Results obtained proved that 50
μg/ml culture is optimal (data not shown). To compare
the stimulatory effect of SEA with phytoheamaglutinine
(PHA), cells were stimulated with PHA at 5 μg/ml culture
medium, other two wells were stimulated with SEA at 50
μg/ml medium, and the last two wells were left un-stimu-
lated as control. Cells were cultured in a humidified
atmosphere at 37°C, 5% CO2 for 7 days. Media were
changed every 48 hours. After 7 days, cells were washed,
permeablized with 0.1% triton X-100 solution (v/v) for 6
min at 4°C, then stained with 50 μg/ml propidium iodide
(PI) as a DNA-specific fluorochrome for 30 min at 4°C in
a dark place. DNA index analysis was performed on FACS
Calibur flow cytometer equipped with logarithmic ampli-
fiers.
Effect of SEA on HCV replication in PBMC
Fifteen ml of blood were withdrawn from each patient
[approved by the medical ethical committee of (NRC)],
five of them were collected on EDTA and were used to
extract total cellular RNA from PBMC (to assess the pres-
ence of intracellular HCV strands in PBMC), the remain-
ing ten ml blood were collected on heparin to separate
PBMC using Ficoll for in vitro experiments. Cells were
washed 5 times with PBS, then re-suspended in RPMI
1640 supplemented with 10% FCS at a concentration of
0.75 × 106/ml, plated on a 6 well plate, and cultured at
37°C, 5% CO2 in absence or presence of SEA (50 μg/ml
culture). After 72 hr, cells were counted (using haemocy-
tometer), collected, washed seven times with PBS, then
subjected to RNA extraction with guanidinium isothiocy-
anate according to Chomczynski and Sacchi [15].
Reverse transcription – polymerase chain reaction (RT-PCR)
Total cellular RNA was reverse transcribed to cDNA in 25
μl reaction mixture containing 20 U of AMV reverse tran-
scriptase (promega, Madison, WI, USA), 200 μM of each
dNTP, 25 pmoles of either antisense primer (1CH: 5' -
GGT GCA CGG TCT ACG AGA CCT-3') for plus strand or
sense primer (2CH: 5' -AAC TAC TGT CTT CAC GCA GAA
-3') for minus strand. The first round PCR was done in a
total volume of 50 μl containing 200 μM of each dNTP, 1
× reaction buffer (10 mM Tris-HCl pH 8.8, 1.5 mM
MgCl2, 50 mM KCl and 0.1% triton X-100), 2 U Taq
polymerase (Finnzyme, Finland), 50 pmoles from each
primer (2 CH and P2: 5' -TGC TCA TGG TGC ACG GTCBMC Infectious Diseases 2006, 6:91 http://www.biomedcentral.com/1471-2334/6/91
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TA -3'). Amplification was performed by 35 cycles of ther-
mal cycling, each consists of denaturation at 94°C for 1
min, annealing at 55°C for 1 min and extension at 72°C
for 1 min followed by a final extension step for additional
10 min. The reaction was then cooled to 4°C. Twenty per-
cent of the reaction was taken for a second amplification
round (35 cycles) with the internal pair of primers (D1: 5'-
CGC AGA AAG CGT CTA GCC AT -3' and D2: 5' -ACT
CGG CTA GCA GTC TCG CG -3'). Cycling conditions on
the thermal cycler were the same as the first round. Prod-
ucts of PCR were analyzed on 2% agarose gel electro-
phoresis and photographed.
Quantification of intracellular HCV RNA
Plus-strand RNA was transcribed in vitro (using sp7 primer
and transcription in vitro kit, Promega, WI) using as tem-
plate a cloned fragment containing the entire 5' UTR in
PGEM-T plasmid (unpublished data). 5' UTR RNA was
quantified spectrophotometrically and standard amounts
(2 × 106 – 2 × 107 copies) were reverse transcribed and
amplified using the method described above. Amplified
products from standard concentrations of 5' UTR RNA
and from infected PBMC were resolved on 2% agarose gel
stained with ethidium bromide. Polaroid photographed
gels were scanned and the intensity of the amplified bands
were analyzed using Total Lab software (Phoretix, New
Castle, UK). Number of copies of plus-strand RNA in each
specimen was calculated on the standard curve. The later
was made from serial dilutions of RNA prepared by in vitro
transcription and the intensity units of scanned amplified
bands using software units.
Results
Detection of HCV in circulating PBMC
Plus HCV RNA strand was detectable in sera and PBMC
derived from all the 26 HCV patients. Both plus and
minus RNA strands were detectable in PBMC of 21
patients, the remaining 5 patients had only plus strand
detectable in their circulating PBMC (Table 1).
Effect of SEA on PBMC proliferation
Flow cytometric analysis showed that the mean ± S.D. of
percent values of cell proliferation from 5 control un-
stimulated cell cultures at day 7 was 3.2 ± 1.5 %. Stimula-
tion of the 5 control cultures with PHA and SEA resulted
in a significant (p < 0.01) increase in DNA index to 16.7 ±
2.5 % and 16.84 ± 1.7 % respectively (figure 1).
Effect of SEA on cultured PBMC count from HCV patients
Stimulation of patients' PBMC in culture for 72 hours
resulted in increased PBMC count in all cases ranging
from 2 – 5 fold increase with a mean value of 4.26 ± 1.5
Table 1: Results of RT-PCR amplification of plus and minus RNA strands in circulating PBMC from 26 HCV positive patients.
Patients Age Sex Genotype Serum Plus strand PBMC Plus strand +ve PBMC Minus strand
R.F. 35  4 ++ +
M.H. 46  4 ++ +
S.H. 45  4 ++ +
M.AA. 40  4 ++ +
809 37  4 ++ -
K.I. 30  4 ++ +
G.B. 37  4 ++ +
S.A. 36  1b ++ +
F.AA. 42  4 ++ +
no 47 45  4 ++ +
A.N 37  4 ++ +
M.W. 40  4 ++ +
A.AZ. 37  4 ++ -
Y.AM. 42  1b ++ +
R.M. 42  4 ++ +
no 51 53  4 ++ +
A.M. 47  4 ++ +
M.A. 42  4 ++ +
AH.AZ. 45  4 ++ -
A 730 47  4 ++ +
A.A. 43  4 ++ +
M.O. 45  4 ++ +
K.M. 48  4 ++ +
A.S. 38  4 ++ +
S.Y. 36  4 ++ -
S.K. 43  4 ++ -BMC Infectious Diseases 2006, 6:91 http://www.biomedcentral.com/1471-2334/6/91
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compared to non stimulated patients' cells that showed
mean increase in cell count ranging from 1.3–2.3 fold
only with a mean value of 1.75 ± 0.25 (Fig 2).
Effect of SEA on HCV replication in PBMC in vitro
Quantification of the intracellular viral load (table 2)
showed increased copy number/cell of both or either viral
strands after stimulation with SEA in 18 of 26 patients
(69.2%) thus indicating induction of viral replication (Fig
3, table 2). Five out of 21 (23.8%) patients lost preexisting
viral strands upon culture. SEA stimulated cells of those
patients showed restoration of either or both strands
(Table 2).
Discussion
In Egypt, viral hepatitis along with schistosomiasis is the
major cause of chronic liver disease and liver cirrhosis [16-
18].  The present study provides, on molecular bases,
ample evidence that SEA treatment in vitro induces HCV
replication and therefore may explain the higher disease
severity in subjects co-infected with HCV and Schisto-
somiasis. The notion that intracellular HCV replication
was induced in vitro by SEA in 69% of patients represents
the first direct evidence on the role of this potent mitogen
Results of PCR amplification of intracellular plus (+) and  minus (-) RNA strands in PBMC derived from HCV patients  before (C) and after stimulation with SEA in inducible (A) and  non inducible (B) PBMC cultures Figure 3
Results of PCR amplification of intracellular plus (+) and 
minus (-) RNA strands in PBMC derived from HCV patients 
before (C) and after stimulation with SEA in inducible (A) and 
non inducible (B) PBMC cultures. M is the molecular weight 
marker.
(A)
(B)
Flow cytometric analysis of cell proliferation (S+G2M) of  PBMC Figure 1
Flow cytometric analysis of cell proliferation (S+G2M) of 
PBMC. A) Normal un-stimulated PBMC, B) Normal PBMC 
stimulated with 5 μg/ml PHA, C) Normal PBMC stimulated 
with 50 μg/ml SEA after 7 days of culture.
Mean ± S.D. value of cell counts of PBMC cultures from 26  HCV patients with (B) and without (A) SEA stimulation Figure 2
Mean ± S.D. value of cell counts of PBMC cultures from 26 
HCV patients with (B) and without (A) SEA stimulation.BMC Infectious Diseases 2006, 6:91 http://www.biomedcentral.com/1471-2334/6/91
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on HCV replication. It also suggests that individual host
factors play distinct roles in determining viral response in
vitro and perhaps the overall morbidity in patients co-
infected with the two diseases. Several cellular proteins
such as Elongation factor 3 (elfa 3), ribosomal proteins S5
and S9 and Eukaryotic translation initiation factor (eIf 3),
the polypyrimidine tract binding protein (PTB), heteroge-
nous nuclear ribonucleoprotein C (hnRNPC) and la anti-
gen were shown to regulate translation of HCV
polyprotein precursor and hence intracellular replication
of viral genome [19-22]. Since PBMC have a major contri-
bution into the circulatory pool of HCV load the results
presented herein may explain why HCV titers are higher in
patients with co-infection than those infected with HCV
alone [23,24]. Furthermore we can not exclude similar
role of SEA on hepatocytes harboring HCV genome in co-
infected patients. Culturing the PBMC resulted in loss of
both plus and minus RNA strands in 23.8% of cases. Inter-
estingly SEA was capable of restoring either one or both
strands in those cultures. This strengthens our hypothesis
that SEA acts as a direct inducer of viral replication and
makes it a valuable stimulatory reagent if future plans are
considered to use short term PBMC cultures for antiviral
screening. Recently, combinations of mitogens and/or
cytokines were found to be able of stimulating synthesis
of plus and minus RNA strands of HCV in PBMC and, in
certain cases, affinity-purified T and B cells [25]. The exact
mechanism whereby SEA stimulates HCV replication is
not yet clear. A mechanism involving extracellular signal-
ing of the growth factor components of SEA is perhaps
implicated. In agreement with the current data, Kamal et
al.,[23] concluded that co-occurrence of the two diseases
was characterized by higher HCV RNA titers, histological
activity, incidence of cirrhosis and hepatocellular carci-
noma (HCC) compared to HCV infection alone. In the
present study, the 5 fold increase in DNA index after 7
days and the observed 2.5 fold increase in PBMC count
after 72 hour exposure to SEA indicate that SEA mediated
cell proliferation involves increased rate of cellular DNA
replication. In this regard both SEA and the commercial
cellular mitogen PHA exerted similar magnitudes of DNA
replication in the studied controls within 7 days of cul-
ture. Reports on other cell systems from our laboratory
[14] and others [26,27] demonstrated that SEA associated
cell proliferation involved up-regulation of cell cycle con-
trolling genes such as peripheral cell nuclear antigen
(PCNA) and B-cell translocation gene 1 (BTG1). Previous
studies [28] reported that most soluble egg antigen frac-
tions elicited in vitro granuloma reactions by PBMC of
almost all Schitosoma haematobium infected patients and in
Table 2: Effect of SEA on HCV replication in PBMC in vitro
patients Before stimulation (copies/cell) After stimulation (copies/cell) Induction
Plus minus Plus minus
R.F. 169 196 496 148 I
M.H. 146 93 UD 119 I
S.H. UD UD 64 64 I
M.AA. 125 UD UD UD NI
809 73 64 79 64 I
K.I. UD UD UD 122 I
G.B. 42 51 64 UD I
S.A. 185 UD 234 UD I
F.AA. 100 UD UD UD NI
no 47 92 137 126 UD I
A.N UD UD UD 86 I
M.W. 100 100 100 105 I
A.AZ. UD 64 UD 64 NI
Y.AM. 64 64 64 86 I
R.M. UD 100 100 100 NI
no 51 264 264 235 228 NI
A.M. UD UD UD 122 I
M.A. 24 UD 38 84 I
AH.AZ. 104 100 100 90 NI
A 730 345 404 100 346 NI
A.A. 73 73 104 100 I
M.O. 182 257 185 259 I
K.M. 73 73 73 79 I
A.S. UD UD 64 UD I
S.Y. UD UD UD UD NI
S.K. UD UD UD UD NI
UD: undetected, I: induced, NI: non inducedBMC Infectious Diseases 2006, 6:91 http://www.biomedcentral.com/1471-2334/6/91
Page 6 of 7
(page number not for citation purposes)
vivo via endothelial cell proliferation [12,29] Conversely,
separated soluble adult-worm antigens failed to stimulate
PBMC of infected patients to form granulomas [28] sug-
gesting that SEA contains unique factor (s) which are lack-
ing in adult worm antigens. Furthermore, the role of SEA
in PBMC proliferation has been well established as an ini-
tial step for angiogenesis and granuloma formation in
Schistosomiasis patients by up-regulation of vascular
endothelial cell growth factor. In HCC, the proliferative
activity of vascular endothelial cells is suggested to play an
important role in the positive regulation of tumor – asso-
ciated vascular endothelial cell proliferation [30]. How-
ever, in vitro stimulatory effect of SEA on PBMC from
chronic HCV patients was scarcely investigated. The signif-
icance of PBMC in chronic hepatitis C patients is based on
the fact that PBMC represent a large extrahepatic reservoir
for HCV replication. We and others have shown that
PBMC from chronic HCV patients do not only contain
HCV genomes but also function to maintain genomic rep-
lication [31-34] and to support viral core and envelope
glycoprotein E1 expression in culture [34-36]. The two
mitogens tested in the present study appeared not to have
the same function on intracellular HCV titers indicating
that different mechanisms of mitogen-viral interactions
are involved. Induction of viral replication does not
always correlate with increased cell proliferation, as SEA
induced cell proliferation was notable in all patients even
those whom intracellular HCV replication was not
induced. Taken together the dual stimulatory function on
both PBMC and viral copies per cell, the magnitude of
total viral pool response in SEA stimulated culture is obvi-
ously larger than the currently presented values, in table 2,
as viral copies per cell. The stimulatory function of SEA on
replication of DNA viruses was reported as early as 1989
when Ishii et al.,[37] reported that SEA from Schistosoma
japonicum induced Epstein Barr virus RNA in lymphoblas-
toid cells.
Conclusion
The present study suggests that SEA possesses potent in
vitro proliferative activity on PBMC and provides the first
evidence that SEA directly stimulates HCV replication in
vitro . This may explain, at least in part, the higher morbid-
ity observed in patients co-infected with Schistosomiasis
and HCV.
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